UA91497C2 - ПРИМЕНЕНИЕ ПЕПТИДОВ, ВЫДЕЛЕННЫХ ИЗ ЦЕПИ Bb ЧЕЛОВЕЧЕСКОГО ФИБРИНОГЕНА, ДЛЯ ЛЕЧЕНИЯ ШОКА - Google Patents
ПРИМЕНЕНИЕ ПЕПТИДОВ, ВЫДЕЛЕННЫХ ИЗ ЦЕПИ Bb ЧЕЛОВЕЧЕСКОГО ФИБРИНОГЕНА, ДЛЯ ЛЕЧЕНИЯ ШОКАInfo
- Publication number
- UA91497C2 UA91497C2 UAA200604047A UAA200604047A UA91497C2 UA 91497 C2 UA91497 C2 UA 91497C2 UA A200604047 A UAA200604047 A UA A200604047A UA A200604047 A UAA200604047 A UA A200604047A UA 91497 C2 UA91497 C2 UA 91497C2
- Authority
- UA
- Ukraine
- Prior art keywords
- moiety
- denotes
- shock
- peptide
- alpha
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Изобретение относится к применению пептида общей формулы IIгдеRи R, одинаковые или разные, представляют водород, насыщенную или ненасыщенную углеводородную часть, которая содержит от 1 до 10 атомов углерода,Z- гистидиновая или пролиновая часть,Arg - аргининовая часть,Z- пролиновая или валиновая часть,Z- лейциновая или валиновая часть,Z- пептидная часть, полученная из цепи Вβ фибрина,причем пептид биологически способен соответствовать индуцированной связующей VЕ-кадгерин части цепи Вβ ( то есть Вβ) человеческого фибрина, для изготовления фармацевтического препарата для лечения шока.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0108704A AT414097B (de) | 2004-06-25 | 2004-06-25 | Pharmazeutische zubereitung zur behandlung von schock |
Publications (1)
Publication Number | Publication Date |
---|---|
UA91497C2 true UA91497C2 (ru) | 2010-08-10 |
Family
ID=35508712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200604047A UA91497C2 (ru) | 2004-06-25 | 2005-06-24 | ПРИМЕНЕНИЕ ПЕПТИДОВ, ВЫДЕЛЕННЫХ ИЗ ЦЕПИ Bb ЧЕЛОВЕЧЕСКОГО ФИБРИНОГЕНА, ДЛЯ ЛЕЧЕНИЯ ШОКА |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN1842344A (ru) |
AT (1) | AT414097B (ru) |
UA (1) | UA91497C2 (ru) |
ZA (1) | ZA200602053B (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT502987A1 (de) | 2005-12-23 | 2007-07-15 | Fibrex Medical Res & Dev Gmbh | Pharmazeutische zusammensetzung zur behandlung von hämorrhagischem schock und seinen folgeerscheinungen |
CN101937002A (zh) * | 2010-07-23 | 2011-01-05 | 合肥天一生物技术研究所 | 血红蛋白目测试剂 |
EP2844270A4 (en) * | 2012-03-15 | 2016-01-27 | Univ New York State Res Found | POLYTHERAPIES INCLUDING EXTRACELLULAR DOMAIN INHIBITORS OF E-CADHERHINE |
-
2004
- 2004-06-25 AT AT0108704A patent/AT414097B/de not_active IP Right Cessation
-
2005
- 2005-06-24 ZA ZA200602053A patent/ZA200602053B/en unknown
- 2005-06-24 UA UAA200604047A patent/UA91497C2/ru unknown
- 2005-06-24 CN CNA2005800009931A patent/CN1842344A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1842344A (zh) | 2006-10-04 |
ZA200602053B (en) | 2007-06-27 |
ATA10872004A (de) | 2005-12-15 |
AT414097B (de) | 2006-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL173969A0 (en) | Use of peptides derived from the a alpha or b beta chain of human of human fibrinogen for the treatment of shock | |
WO2006113681A3 (en) | Plant-derived elastin binding protein ligands and methods of using the same | |
DK0750506T3 (da) | Bredspektrede, antimikrobielle forbindelser og fremgangsmåder til anvendelse af disse | |
AR062065A1 (es) | Anticuerpo humanizado | |
AR036196A1 (es) | Agentes de contraste multimericos dirigidos a base de peptidos | |
NZ593815A (en) | Tissue factor pathway inhibitor (tfpi) inhibitors and methods of use | |
WO2005116051A3 (de) | An mhc-moleküle bindende tumor-assoziierte peptide | |
AU2003264419A1 (en) | Kdr peptides and vaccines containing the same | |
DK2231860T3 (da) | Polypeptid afledt protein A og i stand til at binde PDGF | |
WO2009004315A8 (en) | Isolated peptides and uses thereof | |
WO2005097828A3 (en) | Peptides of cav2.2 that inhibit pain | |
EP1071443A4 (en) | ISOLATED PEPTIDES CORRESPOND THE NY-ESO-1 AMINO ACID SEQUENCES AND BIND TO MHC CLASS I AND MHC CLASS II MOLECULES AND THEIR USE | |
ATE455792T1 (de) | Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon | |
UA91497C2 (ru) | ПРИМЕНЕНИЕ ПЕПТИДОВ, ВЫДЕЛЕННЫХ ИЗ ЦЕПИ Bb ЧЕЛОВЕЧЕСКОГО ФИБРИНОГЕНА, ДЛЯ ЛЕЧЕНИЯ ШОКА | |
YU53803A (sh) | Peptidi i/ili proteini kao i njihova primena za pripremanje terapeutskih i/ili preventivnih lekova | |
WO2007013358A3 (en) | Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent | |
ATE538806T1 (de) | Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren | |
WO2007066018A3 (fr) | Peptides qui peuvent se lier a la proteine nef et leurs applications pharmaceutiques | |
DE602006017806D1 (de) | Behandlung von neurodegeneration | |
AR026068A1 (es) | Peptidos modificados y peptidomimeticos para el uso en inmunoterapia. | |
WO2005087809B1 (en) | Peptides from vitronectin and their therapeutic exploitation for osteoblast adhesion | |
PL1625152T3 (pl) | Peptydy modelujące aktywność czynnika transkrypcyjnego Engrailed | |
EP1724346A3 (de) | An die Lck-SH3 und Hck-SH3 Domäne bindende Peptide | |
WO2022200327A3 (de) | Verwendung von d-enantiomeren peptidliganden von monomerem a-synuclein für die therapie verschiedener synucleinopathien | |
IL151211A0 (en) | Compositions useful for regulating parkin gene activity |